
# Enum: TreatmentArmEnum




URI: [https://w3id.org/pcdc/model/TreatmentArmEnum](https://w3id.org/pcdc/model/TreatmentArmEnum)


## Other properties

|  |  |  |
| --- | --- | --- |

## Permissible Values

| Text | Description | Meaning | Other Information |
| :--- | :---: | :---: | ---: |
| MAP-GR | A control arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) after good response to the MAP regimen pre-operatively. | ncit:C186769 |  |
| MAP-IFN-GR | An experimental treatment arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) plus interferon (IFN) post-operatively after good response to the MAP regimen pre-operatively. | ncit:C186770 |  |
| MAP-PR | A control arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) after poor response to the MAP regimen pre-operatively. | ncit:C186771 |  |
| MAP-IE-PR | An experimental treatment arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) plus a regimen of ifosfamide and etoposide (IE) post-operatively after poor response to the MAP regimen pre-operatively. | ncit:C186772 |  |
| MAP-NR | A control arm for patients receiving a regimen of methotrexate, doxorubicin and cisplatin (MAP) with no response. | ncit:C186773 |  |

